ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,807 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselCORETAG Therapeutics AG
CORETAG Therapeutics AG Logo
Verified· 2 sources

CORETAG Therapeutics AG

Summary

About the company

The core activity of Coretag is the development of therapeutics for the treatment of cancer, particularly through the development of platforms for targeted tumor treatment. The company focuses on developing innovative solutions to improve treatment outcomes and the quality of life for cancer patients.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Pharmaceutical Industry
✓ Offered2
Tumor necrosis targeting platform
Platform for targeted engagement of tumor necroses to uncover hidden cancer cells and improve treatment outcomes for cancer patients.
Pipeline for oncology drug programmes
Pipeline with development projects around NC-Scan, CyanTag, CyanCore and HQ4 in the field of targeted cancer treatment.

Knowledge

No knowledge articles yet

Once CORETAG Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

CORETAG Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank CORETAG Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of CORETAG Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Malzgasse 18
4052 Basel

At a glance

Legal form
Corporation
UID
CHE-251.041.677
Founded
2020 · 6 years
Last commercial register change
December 10, 2024
Employees
1 to 10

Similar companies

SA
SpiroChem AG
Basel
SA
Scailyte AG
Basel
ST
Synendos Therapeutics AG
Basel
TT
TargImmune Therapeutics AG
Basel